285 related articles for article (PubMed ID: 25582686)
21. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
22. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
[TBL] [Abstract][Full Text] [Related]
23. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
24. Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.
Ha SJ; Park SH; Kim HJ; Kim SC; Kang HJ; Lee EG; Kwon SG; Kim BM; Lee SH; Kim WB; Sung YC; Cho SN
Infect Immun; 2006 Aug; 74(8):4954-9. PubMed ID: 16861689
[TBL] [Abstract][Full Text] [Related]
25. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
Tanghe A; Denis O; Lambrecht B; Motte V; van den Berg T; Huygen K
Infect Immun; 2000 Jul; 68(7):3854-60. PubMed ID: 10858194
[TBL] [Abstract][Full Text] [Related]
27. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
[TBL] [Abstract][Full Text] [Related]
28. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.
Parlane NA; Wedlock DN; Buddle BM; Rehm BH
Appl Environ Microbiol; 2009 Dec; 75(24):7739-44. PubMed ID: 19837843
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
[TBL] [Abstract][Full Text] [Related]
30. Improved tuberculosis DNA vaccines by formulation in cationic lipids.
D'Souza S; Rosseels V; Denis O; Tanghe A; De Smet N; Jurion F; Palfliet K; Castiglioni N; Vanonckelen A; Wheeler C; Huygen K
Infect Immun; 2002 Jul; 70(7):3681-8. PubMed ID: 12065510
[TBL] [Abstract][Full Text] [Related]
31. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
[TBL] [Abstract][Full Text] [Related]
32. Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA.
Montgomery DL; Huygen K; Yawman AM; Deck RR; Dewitt CM; Content J; Liu MA; Ulmer JB
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):285-92. PubMed ID: 9193782
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of a DNA Vaccine Encoding Ag85a-Tb10.4 Antigens from Mycobacterium Tuberculosis.
Meshkat Z; Teimourpour A; Rashidian S; Arzanlou M; Teimourpour R
Iran J Immunol; 2016 Dec; 13(4):289-295. PubMed ID: 27999240
[TBL] [Abstract][Full Text] [Related]
34. T-bet acts as a powerful adjuvant in Ag85B DNA‑based vaccination against tuberculosis.
Hu D; Wu J; Zhang R; Chen L
Mol Med Rep; 2012 Jul; 6(1):139-44. PubMed ID: 22552442
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
Lozes E; Huygen K; Content J; Denis O; Montgomery DL; Yawman AM; Vandenbussche P; Van Vooren JP; Drowart A; Ulmer JB; Liu MA
Vaccine; 1997 Jun; 15(8):830-3. PubMed ID: 9234526
[TBL] [Abstract][Full Text] [Related]
36. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
37. [Expression and immunogenicity of Ag85A protein of Mycobacterium tuberculosis].
Xu Z; Hu T; Liu Z; Shen X; Liu J; Yin Y; Sun L; Chen X; Jiao X
Wei Sheng Wu Xue Bao; 2016 May; 56(5):804-13. PubMed ID: 29727142
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.
Denis O; Tanghe A; Palfliet K; Jurion F; van den Berg TP; Vanonckelen A; Ooms J; Saman E; Ulmer JB; Content J; Huygen K
Infect Immun; 1998 Apr; 66(4):1527-33. PubMed ID: 9529077
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
Meerak J; Wanichwecharungruang SP; Palaga T
Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
[TBL] [Abstract][Full Text] [Related]
40. CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A.
D'Souza S; Denis O; Scorza T; Nzabintwali F; Verschueren H; Huygen K
Eur J Immunol; 2000 Sep; 30(9):2455-9. PubMed ID: 11009076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
